N-Boc-erythro-L-β-methylphenylalanine is a chiral, non-proteinogenic amino acid derivative. Its structure features a phenylalanine backbone with a β-methyl substituent in the erythro configuration relative to the amino group, and the α-amino functionality is protected by a tert-butoxycarbonyl (Boc) group. This specific stereochemistry is crucial for its applications. This compound serves as a key chiral building block in the synthesis of complex bioactive molecules. Its primary application is in medicinal chemistry and peptide research, where it is used to introduce a constrained, methyl-substituted phenylalanine moiety into peptide sequences. This modification is employed to enhance metabolic stability, modulate conformational properties, and improve the binding affinity and selectivity of peptide-based drug candidates, particularly in the development of protease inhibitors and other therapeutic peptides. As a Boc-protected amino acid, it is a stable, crystalline solid suitable for standard peptide coupling reactions. The erythro-L-β-methyl configuration makes it a valuable and specialized intermediate, distinguishing it from more common phenylalanine derivatives. It is typically handled under standard laboratory conditions for air- and moisture-sensitive compounds.